Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2024-07-11 00:00:00 ET · period of report 2024-07-09 · accession 0001171843-24-003903 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-11 | 2024-07-09 | ANIK | Capper Joseph H | Dir | A - Grant | $0.00 | +5,771 | 6,239 | +1,233% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-09 | A | A | 5,771 | $0.00 | 6,239 | D | — | — | (F1) These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025. |